close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis  

What's this?
Pound69Point95
Implied share price

Buy Undervalued by 35.6%

5% margin of safety What's this?

EV / EBITDA
Use Average
AZN
AstraZeneca plc
JNJ
Johnson & Johnson
Change
NVS
Novartis AG (ADR)
Change
PFE
Pfizer Inc.
Change
MRK
Merck & Co., Inc.
Change
11.78 8.94 12.21 13.2 11.9 9.04
All amounts in millions
from last financial year
         
Implied Share Price £69.95 $114.02 $71.56 $33.90 $82.09
Market Cap 64,996 322,696 212,603 207,930 171,277
Net Debt 8,200 -18,515 16,599 15,609 12,985
Enterprise Value (EV) 73,435 304,181 209,620 223,539 184,261
Revenue 24,708 70,074 50,359 48,851 39,498
EBITDA 8,210 24,918 15,880 18,788 20,379
Percent 33.2 % 35.6 % 31.5 % 38.5 % 51.6 %
EBIT 5,929 21,172 10,655 13,631 14,004
Percent 24.0 % 30.2 % 21.2 % 27.9 % 35.5 %
Balance Sheet          
Total Assets 60,124 133,411 131,556 167,381 101,677
Total Liabilities 41,634 62,261 54,510 102,661 57,001
Shareholders Equity 18,490 71,150 77,046 64,720 44,676.0

Comments

No comments yet. Login to comment.